215 related articles for article (PubMed ID: 27807028)
21. Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase.
Ling P; Yao Z; Meyer CF; Wang XS; Oehrl W; Feller SM; Tan TH
Mol Cell Biol; 1999 Feb; 19(2):1359-68. PubMed ID: 9891069
[TBL] [Abstract][Full Text] [Related]
22. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
23. Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.
Koval AP; Karas M; Zick Y; LeRoith D
J Biol Chem; 1998 Jun; 273(24):14780-7. PubMed ID: 9614078
[TBL] [Abstract][Full Text] [Related]
24. In vivo regulation of CrkII and CrkL proto-oncogenes in the uterus by insulin-like growth factor-I. Differential effects on tyrosine phosphorylation and association with paxillin.
Butler AA; Blakesley VA; Koval A; deJong R; Groffen J; LeRoith D
J Biol Chem; 1997 Oct; 272(44):27660-4. PubMed ID: 9346905
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2.
Zhang ZS; Yang DY; Fu YB; Zhang L; Zhao QP; Li G
Cell Biochem Funct; 2015 Mar; 33(2):80-8. PubMed ID: 25703803
[TBL] [Abstract][Full Text] [Related]
26. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
Lamorte L; Royal I; Naujokas M; Park M
Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644
[TBL] [Abstract][Full Text] [Related]
27. Cell shape-based chemical screening reveals an epigenetic network mediated by focal adhesions.
Kanazawa T; Michida H; Uchino Y; Ishihara A; Zhang S; Tabata S; Suzuki Y; Imamoto A; Okada M
FEBS J; 2021 Oct; 288(19):5613-5628. PubMed ID: 33768715
[TBL] [Abstract][Full Text] [Related]
28. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.
Pham TH; Gao X; Singh G; Hardwidge PR
J Biol Chem; 2013 Nov; 288(48):34567-74. PubMed ID: 24145029
[TBL] [Abstract][Full Text] [Related]
30. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
[TBL] [Abstract][Full Text] [Related]
31. Reduction of Crk and CrkL expression blocks reelin-induced dendritogenesis.
Matsuki T; Pramatarova A; Howell BW
J Cell Sci; 2008 Jun; 121(11):1869-75. PubMed ID: 18477607
[TBL] [Abstract][Full Text] [Related]
32. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
Sanders MA; Ampasala D; Basson MD
J Biol Chem; 2009 Jan; 284(1):27-35. PubMed ID: 19004829
[TBL] [Abstract][Full Text] [Related]
33. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
34. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
[TBL] [Abstract][Full Text] [Related]
35. Proapoptotic function of the nuclear Crk II adaptor protein.
Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
[TBL] [Abstract][Full Text] [Related]
36. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
37. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
[TBL] [Abstract][Full Text] [Related]
38. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
39. Crk associates with a multimolecular Paxillin/GIT2/beta-PIX complex and promotes Rac-dependent relocalization of Paxillin to focal contacts.
Lamorte L; Rodrigues S; Sangwan V; Turner CE; Park M
Mol Biol Cell; 2003 Jul; 14(7):2818-31. PubMed ID: 12857867
[TBL] [Abstract][Full Text] [Related]
40. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
